Franklin Covey Co. Q3 2026 Earnings Call Summary

Franklin Covey Co. reported Q3 2026 momentum driven by higher client retention/expansion and North America enterprise growth, including a third straight quarter of rising invoiced amounts. Services booking pace rose 25% YTD. Fiscal 2027 outlook calls for faster revenue growth and operating leverage, but revenue guidance was cut ~$6M due to timing, education budget, and geopolitical impacts; gross margin fell to 73.9% from 76.5%.

Original reporting
Published Jul 3, 2026, 10:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 3, 2026, 10:57 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Franklin Covey Co. Q3 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

$FCNeutralMed
01

Why it matters

Key new trading inputs are the revised revenue guidance (~$6M lower), gross margin decline to 73.9%, and FY2027 forward framing: +18% YoY deferred revenue in North American Enterprise and expected operating leverage as transformation investments are largely complete.

02

Market read

Traders can reassess FY2027 growth quality and margin trajectory using the call’s concrete guidance/margin/deferred-revenue datapoints.

03

What to watch

China strategy optionality (direct vs licensee) could materially change the growth profile; investors may also underweight the impact of restructuring expenses and delivery-cost/mix shifts on near-term margins.

Relevance 7/10Novelty 6/10Timing: ahead of FY2027 positioning and near-term investor repricing after the earnings call summary

Background

The piece summarizes Franklin Covey’s Q3 2026 earnings call, focusing on North America enterprise retention/expansion, education subscription dynamics, and international headwinds.

Company-level read

Ticker impact

$FCNeutralMedium confidence
Context

Franklin Covey’s call summary cites revised revenue guidance (~$6M lower) plus FY2027 deferred-revenue growth and operating-leverage expectations.

Expected impact

Choppy-to-lower reaction risk if investors focus on the ~$6M guidance cut and gross-margin decline; upside if they buy the FY2027 leverage/deferred-revenue acceleration.

Evidence & confidence

The article provides multiple concrete datapoints (guidance revision, deferred revenue +18% YoY, gross margin down to 73.9%, restructuring costs) but lacks the actual earnings numbers, limiting precision on magnitude.

Market effects

Highlights demand narrative for AI leadership/coaching training and services attach rates, relevant to enterprise learning/content-to-outcomes repositioning.

North America Enterprise strength is emphasized, while China macro/geopolitical headwinds are flagged as an ongoing drag.

International expansion plan (exporting the North American sales model starting Europe in FY2027 Q1) may influence expectations for cross-region services growth.

Counterpoint

The guidance cut is driven by timing (rescheduled delivery and budget veto) and may be less fundamental than it appears, while the gross-margin decline could be mix-related and reversible.

Key entities

  • Franklin Covey Co.

    Subject of the earnings call summary; guidance revision, margin change, and FY2027 outlook are discussed.

Related articles

$FCMed

Franklin Covey (FC) Q4 2026 Earnings Call Transcript

Franklin Covey (FC) reported Q4 2026 growth in Enterprise North America, with invoiced amounts up 4% to $151.4M and deferred revenue up 17% to $59.2M. The company expects fiscal 2027 revenue and adjusted EBITDA growth, driven by a resilient core and successful go-to-market transformation. Education business is expected to return to growth, and AI trends support the company's durability.

$FCMed

Franklin Covey Co (FC) (Q4 2026) Earnings Call Highlights: Navigating Revenue Headwinds

Franklin Covey (FC) reported China as 2% of fiscal 2026 revenue, with a transition to a licensee model expected to reduce revenue by $2 million but remain EBITDA neutral. CFO Jesse guided to 45-50% of annual revenue in the first half of fiscal 2027, with restructuring savings increasing EBITDA through the year. CEO Paul Walker noted improved revenue retention and plans to expand the sales team by over 20%.

$FCMedAI 8/10

Why Franklin Covey Stock Plummeted Today

Franklin Covey (FC) shares fell 12.9% on Thursday after the company reported Q3 FY2026 results (ended May 31) below Wall Street expectations and issued weaker-than-expected forward guidance. EPS was $0.27 on sales of $67.8M vs estimates of about $0.31 on ~$68.3M revenue; guidance called for $260M–$267M sales vs prior $265M–$275M.

$FCMed

FRANKLIN COVEY REPORTS THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS

FRANKLIN COVEY CO (FC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 fc-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Press Release 13907 S. Minuteman Drive, Suite 500 Draper, UT 84020 www.franklincovey.com FRANKLIN COVEY REPORTS THIRD QUARTER FISCAL 2026 FINANCIAL RESULTS Consolidated Third Quarter Revenue Increases 1% to $67.8 Million Invoic